Identification of Radio-resistant Gene by Microarray in Head and Neck Cancer

碩士 === 長庚大學 === 生化與生醫工程研究所 === 92 === Abstract Head and neck cancer is one of the ten frequent cancer in the world with an estimated over 500,000 new cases being diagnose annually. The overall 5-year survival rate for patients with head and neck cancer is among the lowest of th...

Full description

Bibliographic Details
Main Authors: Wei Chung Laio, 廖偉成
Other Authors: Ann Joy Cheng
Format: Others
Language:en_US
Published: 2004
Online Access:http://ndltd.ncl.edu.tw/handle/74222162092242710990
id ndltd-TW-092CGU00723013
record_format oai_dc
spelling ndltd-TW-092CGU007230132016-01-04T04:08:38Z http://ndltd.ncl.edu.tw/handle/74222162092242710990 Identification of Radio-resistant Gene by Microarray in Head and Neck Cancer 利用微矩陣分析方法篩選頭頸癌細胞中具抵抗放射線之基因 Wei Chung Laio 廖偉成 碩士 長庚大學 生化與生醫工程研究所 92 Abstract Head and neck cancer is one of the ten frequent cancer in the world with an estimated over 500,000 new cases being diagnose annually. The overall 5-year survival rate for patients with head and neck cancer is among the lowest of the major cancer, and has not changed during the past two decades. In Taiwan, the incidence of head and neck cancer has become the 7th leading cancer, the 5th leading cancer in male, and is still increasing in the recent years. Since this cancer usually occurs in middle age male, at the high peak of life responsibility, it has tremendous impact of family and society. Radiation therapy is an integral part of the treatment of head and neck cancer. However, local recurrence or tumor persistence after radiation therapy is the major cause of treatment failure. The sensitivity of tumor cells to the cytotoxicity of ionizing radiation is, therefore, the major determinants of local tumor control in patient treated with radiation therapy. However, the molecular factors predicting radiation response have not been extensively studied, far away from clinical application of molecular adjuvant therapy to increase radio-sensitivity. The aim of this study is to identify genetic alterations associated with our established radio-resistant subclones (KB and OEC-M1cells) from Taiwanese local head and neck cancer. The result of cDNA microarray screening demonstrated that RP105 (Ly64) gene was found in both KB and OEC-M1 radio-resistant subclones, following identified with RT-PCR that expressed in KB and OEC-M1 radio-resistant subclones. Transfection of RP105 RNAi in radio-resistant subclones reversed this phenomenon. RP105 expression was correlated to growth and radio-resistance in OEC-M1, but less significant in KBRR cells. However, RP105 gene was more expression in leukocytes than OEC-M1 and KBRR, so this gene maybe plays important roles of radio-resistance in leukocytes. Ann Joy Cheng 鄭恩加 2004 學位論文 ; thesis 0 en_US
collection NDLTD
language en_US
format Others
sources NDLTD
description 碩士 === 長庚大學 === 生化與生醫工程研究所 === 92 === Abstract Head and neck cancer is one of the ten frequent cancer in the world with an estimated over 500,000 new cases being diagnose annually. The overall 5-year survival rate for patients with head and neck cancer is among the lowest of the major cancer, and has not changed during the past two decades. In Taiwan, the incidence of head and neck cancer has become the 7th leading cancer, the 5th leading cancer in male, and is still increasing in the recent years. Since this cancer usually occurs in middle age male, at the high peak of life responsibility, it has tremendous impact of family and society. Radiation therapy is an integral part of the treatment of head and neck cancer. However, local recurrence or tumor persistence after radiation therapy is the major cause of treatment failure. The sensitivity of tumor cells to the cytotoxicity of ionizing radiation is, therefore, the major determinants of local tumor control in patient treated with radiation therapy. However, the molecular factors predicting radiation response have not been extensively studied, far away from clinical application of molecular adjuvant therapy to increase radio-sensitivity. The aim of this study is to identify genetic alterations associated with our established radio-resistant subclones (KB and OEC-M1cells) from Taiwanese local head and neck cancer. The result of cDNA microarray screening demonstrated that RP105 (Ly64) gene was found in both KB and OEC-M1 radio-resistant subclones, following identified with RT-PCR that expressed in KB and OEC-M1 radio-resistant subclones. Transfection of RP105 RNAi in radio-resistant subclones reversed this phenomenon. RP105 expression was correlated to growth and radio-resistance in OEC-M1, but less significant in KBRR cells. However, RP105 gene was more expression in leukocytes than OEC-M1 and KBRR, so this gene maybe plays important roles of radio-resistance in leukocytes.
author2 Ann Joy Cheng
author_facet Ann Joy Cheng
Wei Chung Laio
廖偉成
author Wei Chung Laio
廖偉成
spellingShingle Wei Chung Laio
廖偉成
Identification of Radio-resistant Gene by Microarray in Head and Neck Cancer
author_sort Wei Chung Laio
title Identification of Radio-resistant Gene by Microarray in Head and Neck Cancer
title_short Identification of Radio-resistant Gene by Microarray in Head and Neck Cancer
title_full Identification of Radio-resistant Gene by Microarray in Head and Neck Cancer
title_fullStr Identification of Radio-resistant Gene by Microarray in Head and Neck Cancer
title_full_unstemmed Identification of Radio-resistant Gene by Microarray in Head and Neck Cancer
title_sort identification of radio-resistant gene by microarray in head and neck cancer
publishDate 2004
url http://ndltd.ncl.edu.tw/handle/74222162092242710990
work_keys_str_mv AT weichunglaio identificationofradioresistantgenebymicroarrayinheadandneckcancer
AT liàowěichéng identificationofradioresistantgenebymicroarrayinheadandneckcancer
AT weichunglaio lìyòngwēijǔzhènfēnxīfāngfǎshāixuǎntóujǐngáixìbāozhōngjùdǐkàngfàngshèxiànzhījīyīn
AT liàowěichéng lìyòngwēijǔzhènfēnxīfāngfǎshāixuǎntóujǐngáixìbāozhōngjùdǐkàngfàngshèxiànzhījīyīn
_version_ 1718158583742332928